Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Intercept Pharmaceut (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,448,772
  • Shares Outstanding, K 25,100
  • Annual Sales, $ 24,950 K
  • Annual Income, $ -412,830 K
  • 36-Month Beta -2.05
  • Price/Sales 13.46
  • Price/Cash Flow N/A
  • Price/Book 11.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.53 +12.01%
on 01/17/18
65.95 -12.48%
on 12/27/17
-3.91 (-6.34%)
since 12/19/17
3-Month
51.53 +12.01%
on 01/17/18
68.00 -15.12%
on 11/01/17
-9.14 (-13.67%)
since 10/19/17
52-Week
51.53 +12.01%
on 01/17/18
135.59 -57.43%
on 07/28/17
-56.95 (-49.66%)
since 01/19/17

Most Recent Stories

More News
Technical Perspectives on Agenus, Coherus Biosciences, Global Blood Therapeutics, and Intercept Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AGEN, CHRS, GBT, and ICPT which can be accessed for free by signing up to www.wallstequities.com/registration....

AGEN : 3.97 (+1.79%)
GBT : 53.95 (+1.79%)
CHRS : 10.75 (-5.70%)
ICPT : 57.72 (+8.52%)
Intercept (ICPT) Stock Loses Sheen in 2017: What Lies Ahead?

Intercept (ICPT) had a tough time in 2017 after news of death were out related to lead drug's Ocaliva's dosing. We do not expect a phenomenal revival in 2018 either.

AGN : 181.33 (+0.94%)
NVS : 86.94 (+0.61%)
GILD : 80.98 (-0.23%)
ICPT : 57.72 (+8.52%)
SmarTrend Watching for Potential Pullback in Shares of Intercept Pharma After 2.26% Gain

Intercept Pharma (NYSE:ICPT) traded in a range yesterday that spanned from a low of $62.50 to a high of $64.36. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of...

ICPT : 57.72 (+8.52%)
Today's Research Reports on Stocks to Watch: Puma Biotechnology and Intercept Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / December 14, 2017 / Shares of Puma Biotechnology closed up over 5% yesterday on news regarding the European Medicines Agency. Shares of Intercept Pharmaceuticals soared higher...

PBYI : 91.60 (+3.80%)
ICPT : 57.72 (+8.52%)
Intercept to Present at Upcoming Conference

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 57.72 (+8.52%)
This Morning's Research Reports on Biotechnology Stocks -- FibroGen, Global Blood Therapeutics, Intercept Pharma, and Nektar Therapeutics

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on FGEN, GBT, ICPT, and NKTR which is a click away at www.wallstequities.com/registration....

GBT : 53.95 (+1.79%)
FGEN : 47.85 (+1.16%)
ICPT : 57.72 (+8.52%)
NKTR : 71.59 (+2.04%)
Today's Research Reports on Trending Tickers: Aeterna Zentaris and Intercept Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 28, 2017 / U.S. markets were mixed Monday as retailers surged on strong holiday sales numbers, while chipmakers and oil stocks dragged. The Dow Jones Industrial Average...

AEZS : 2.28 (unch)
ICPT : 57.72 (+8.52%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT

NEW YORK, NY / ACCESSWIRE / November 23, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT)...

ICPT : 57.72 (+8.52%)
ICPT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intercept Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 27, 2017

NEW YORK, NY / ACCESSWIRE / November 22, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of...

ICPT : 57.72 (+8.52%)
DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of...

ICPT : 57.72 (+8.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR)....

See More

Key Turning Points

2nd Resistance Point 61.60
1st Resistance Point 59.66
Last Price 57.72
1st Support Level 54.51
2nd Support Level 51.30

See More

52-Week High 135.59
Fibonacci 61.8% 103.48
Fibonacci 50% 93.56
Fibonacci 38.2% 83.64
Last Price 57.72
52-Week Low 51.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.